Artificial Organelles Based on Cross-Linked Zwitterionic Vesicles

Yun Chen,Jiangbing Tan,Qian Zhang,Tuo Xin,Yunlong Yu,Yu Nie,Shiyong Zhang
DOI: https://doi.org/10.1021/acs.nanolett.0c02298
IF: 10.8
2020-08-04
Nano Letters
Abstract:Artificial organelles (AOs) are typical microcompartments with intracellular biocatalytic activity aimed to replace missing or lost cellular functions. Currently, liposomes or polymersomes are popular microcompartments to build AOs by embedding channel proteins in their hydrophobic domain and entrapping natural enzymes in their cavity. Herein, a new microcompartment is established by using monolayer cross-linked zwitterionic vesicles (cZVs) with a carboxylic acid saturated cavity. The monolayer structure endows the cZVs with intrinsic permeability; the cavity supplies the cZVs ability of <i>in situ</i> synthesis of artificial enzymes, and the pH-dependent charge-change property makes it possible to overcome the biological barriers. Typically, nanozymes of CeO<sub>2</sub> and Pt NPs were synthesized in the cZVs to mimic peroxisome. <i>In vitro</i> experiments confirmed that the resulting artificial peroxisome (AP) could resist protein adsorption, endocytose efficiently, and escape from the lysosome. <i>In vivo</i> experiments demonstrated that the APs held a good therapeutic effect in ROS-induced ear-inflammation.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.0c02298?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.0c02298</a>.Experimental details (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.0c02298/suppl_file/nl0c02298_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem this paper attempts to address is the construction of a new type of artificial organelle (AO), specifically artificial peroxisomes (AP), to replace missing or dysfunctional organelles and treat various cellular disorders. Currently, artificial organelles are typically constructed by embedding channel proteins and capturing natural enzymes within liposomes or polymer vesicles. However, these methods have drawbacks such as poor stability, heavy synthetic burden, and potential impacts on the integrity and stability of the microcompartment. To overcome these issues, the authors developed a novel microcompartment based on monolayer cross-linked zwitterionic vesicles (cZVs) with carboxylic acid-saturated chambers. These cZVs have the following characteristics: 1. **Intrinsic Permeability**: The monolayer structure endows cZVs with intrinsic permeability to substrates and products. 2. **In Situ Synthesis of Nanozymes**: The chamber can synthesize nanozymes in situ, such as CeO₂ and Pt nanoparticles, to mimic the function of peroxisomes. 3. **pH-Dependent Charge Change**: This feature allows cZVs to overcome biological barriers, such as efficient endocytosis in inflammatory environments and rapid escape from lysosomes. With these characteristics, cZVs can effectively scavenge reactive oxygen species (ROS) and demonstrate good therapeutic effects in in vivo experiments, particularly in an ear inflammation model induced by ROS. This research provides a new platform for constructing artificial organelles for the treatment of various cellular disorders.